Age-related changes of VIP, NPY and somatostatin-immunoreactive neurons in the cerebral cortex of aged rats

Brain Research

Volumn 753, Issue 2, 1997, Pages 235-244

  Cha, Choong Ik ^a   Lee, Young Il ^a   Lee, Eun Young ^b   Park, Kyeong Han ^a   Baik, Sang Ho ^a  

^a Seoul National University   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

Author keywords

aged rat; cerebral cortex; immunocytochemistry; irregular orientation; loss of neurons; NPY; somatostatin; VIP

Indexed keywords

NEUROPEPTIDE Y; SOMATOSTATIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADOLESCENT; AGED; AGING; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

AGING; ANIMALS; CELL COUNT; CEREBRAL CORTEX; IMMUNOHISTOCHEMISTRY; NEURONS; NEUROPEPTIDE Y; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSTATIN; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0031564642     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00009-7     Document Type: Article

References (62)

1. Alexander, P., Robert, C. and Charles, B., Cortical and subcortical neuropeptides in Alzheimer's disease, Neurobiol. Aging, 15 (1994) 589-595.
2. Arai, H., Moroji, T. and Kosaka, K., Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia, Neurosci. Lett., 52 (1984) 73-78.
3. Banker, G.A., Trophic interactions between astroglial cells and hippocampal neurons in culture, Science, 209 (1980) 809-810.
4. Beal, M.F., Kowall, N.W. and Mazurek, M.F., Neuropeptides in Alzheimer's disease, J. Neural Transm. 24 (1987) 163-174.
5. Beal, M.F., Mazurek, M.F., Chattha, G.K., Svendsen, C.N., Bird, E.D. and Martin, J.B., Neuropeptide Y immunoreactivity is reduced in the cerebral cortex in Alzheimer's disease, Ann. Neurol. 20 (1986) 282-288.
6. Benoit, R., Ling, N., Alford, B. and Guillemin, R., Seven peptides derived from prosomatostatin in rat brain, Biochem. Biophys. Res. Commun., 107 (1982) 944.
7. Brenneman, D.E., Neale, E.A., Foster, G.A., d'Autremont, S. and Westbrook, G.L., Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide, J. Cell Biol., 104 (1987) 1603-1610.
8. Brenneman, D.E., Schultzberg, M., Bartfai, T. and Gozes, I., Cytokine regulation of neuronal survival, J. Neurochem., 58 (1992) 454-460.
9. Buetow, D.E., Cell number vs. age in mammalian tissues and organs. In Cristofalo V.J. Adelman R.C. and Roth G.S. (Eds.), CRC Handbook of Cell Biology of Aging, CRC Press, 1985, pp. 1-144.
10. Burks, T.F., Buck, S.H., Yamanura, H.I. and Deshmukh, P.P., Level of substance P, somatostatin, and neurotensin in rodent and human CNS in aging, Age, 4 (1981) 143.
11. Chan-Palay, V., Lang, W., Allen, Y.S., Haesler, U. and Polak, J.M., Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's-type dementia, J. Comp. Neurol. 238 (1985) 390-400.
12. Chan-Palay, V., Lang, W., Haesler, U., Kohler, C. and Yasargil, G., Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer's type dementia, J. Comp. Neurol. 248 (1986) 376-394.
13. Chan-Palay, V., Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: coexistence with neuropeptide Y neurons and effects in Alzheimer-type dementia, J. Comp. Neurol., 260 (1987) 201-223.
14. Colmers, W.F. and Wahlestedt, C., The Biology of Neuropeptide Y and Related Peptides, Humana Press, Totowa, New Jersey, 1993.
15. Cossu, G., Cusella-De Angelis, M.G., Senni, M.I., DeAngelis, L., Vivarelli, E., Vella, S., Bouche, M., Boitani, C. and Molinaro, M., Adrenocorticotrophin is a specific mitogen for mammalian myogenic cells, Dev. Biol., 131 (1989) 331-336.
16. Curcio, C.A., Buell, S.J. and Coleman, P.D., Morophology of the aging central nervous system: not all downhill. In J.A. Mortimer, F.J. Preozzolo and J.G. Maletta (Eds.), The Aging Motor System, Advances in Neurogerontology, Vol. 3, Praeger, 1981, pp. 7-35.
17. Davies, C.A., Morroll, D.R., Prinja, D., Mann, D.M. and Gibbs, A., A quantitative assessment of somatostatin-like and neuropeptide Y-like immunohistochemical cells in the frontal and temporal cortex of patients with Alzheimer's disease, J. Neurol. Sci. 96 (1990) 59-73.
18. Davies, P., Katzman, R. and Terry, R.D., Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer's disease and Alzheimer's senile dementia, Nature, 288 (1980) 279-280.
19. De Souza, E.B., Whitehouse, P.J., Price, D.L. and Vale, W.W., Abnormalities in corticotropin-releasing hormone (CRH) in Alzheimer's disease and other human disorders, Ann. NY Acad. Sci., 512 (1987) 237.
20. De Wied, D. and Jolles, J., Neuropeptides derived from proopiocortin: behavioral, psychological and neurochemical effects, Physiol. Rev., 62 (1982) 976.
21. Dennis-Donini, S., Expression of dopaminergic phenotypes in the mouse olfactory bulb induced by the calcitonin gene-related peptide, Nature, 339 (1989) 701-703.
22. Epelbaum, J., Somatostatin in the central nervous system: physiology and pathological modifications, Progr. Neurobiol., 27 (1986) 63.
23. Ferrier, I.N., Cross, A.J., Johnson, J.A., Roberts, G.W., Crow, T.J., Corsellis, J.A., Lee, Y.C., O'Shaughnessy, D., Adrian, T.E., McGregor, G.P., Baracese-Hamilton, A.J. and Bloom, S.R., Neuropeptides in Alzheimer type dementia, J. Neurol. Sci., 62 (1983) 159-170.
24. Fliers, E. and Swaab, D.F., Activation of vasopressinergic and oxytocynergic neurons during aging in the Wistar rat, Peptides, 4 (1983) 165.
25. Fliers, E., Swaab, D.F., Pool, C.W. and Verwer, R.W.H., The vasopressin and oxytocin neurons in the human supraoptic and paraventricular nucleus: changes with aging and in senile dementia, Brain Res., 342 (1985) 45.
26. Foster, N.L., Tamminga, C.A., O'Donohue, T.L., Tanimoto, K., Bird, E.D. and Chase, T.N., Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's disease, Neurosci. Lett., 63 (1986) 71-75.
27. Glowa, J.R., Panlilio, L.V., Brenneman, D.E., Gozes, I., Fridkin, M. and Hill, J.M., Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist, Brain Res., 570 (1992) 49-53.
28. Gozes, I. and Brenneman, D.E., Neuropeptides as growth and differentiation factors in general and VIP in particular, J. Mol. Neurosci., 4 (1993) 1-9.
29. Gozes, I., Hill, J.M., Mervis, R.F., Fridkin, M. and Brenneman, D.E., VIP antagonist produces neuronal damage and retardation of behavioral development in neonatal rats, Soc. Neurosci. Abstr., 16 (1990) 1292.
30. Gozes, I., Schaechter, P., Shani, Y. and Giladi, E., Vasoactive Intestinal Peptide gene expression from embryos to aging rats, Neuroendocrinology, 47 (1988) 27-31.
31. Gruenewald, D.A., Naai, M.A., Marck, B.T. and Matsumoto, A.M., Age-related decrease in Neuropeptide-Y gene expression in the arcuate nucleus of the male rat brain is independent of testicular feedback, Endocrinology, 134 (1994) 2383-2389.
32. Heilig, M., Neuropeptide Y in Relation to Behavior and Psychiatric Disorders. In W.F., Colmers and C., Wahlestedt (Eds.), The Biology of Neuropeptide Y and Related Peptides. Humana Press, Totowa, New Jersey, 1993, pp. 511-554.
33. Higuchi, H., Hsiu-Ying, T. and Yang, T., Age-related redirctional changes in neuropeptide Y peptides in rat adrenal glands, brain and blood, J. Neurochem., 50 (1988) 1879.
34. Hill, J.M., Gozes, I., Hill, J.L., Fridkin, M. and Brenneman, D.E., Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the rat, Peptides, 12 (1991) 187-192.
35. Joynt, R.J. and McNeil, T.H., Neuropeptides in aging and dementia, Peptides, 5 (1984) 269-274.
36. Kerkerian, L., Bosler, O., Pelletier, G. and Nieoullon, A., Striatal neuropeptide Y neurons are under the influence of the nigrostriatal dopaminergic pathway: immunohistochemical evidence, Neurosci. Lett., 66 (1986) 106-112.
37. Kowall, N.W., Beal, M.F. and Martin, J.B., Neuropeptide Y, somatostatin, and NADPH disphorase neurons do not contain neurofibrillary tangles in Alzheimer's disease, Ann. Neurol., 20 (1986) 124.
38. Kowalski, C., Micheau, J., Corder, R., Gaillard, R. and Conte-Devolx, B., Age-related changes in cortico-releasing factor, somatostatin, neuropeptide Y, methionine enkephalin and β-endorphin in specific rat brain areas, Brain Res., 582 (1992) 38-46.
39. Lucassen, P.J., Salehi, A., Pool, C.W., Gonatas, N.K. and Swaab, D.F., Activation of vasopressin neurons in aging and Alzheimer's disease, J. Neuroendocrinol. 6 (1994) 673-679.
40. Magistretti, P.J., Morrison, J.H., Shoemaker, W.J., Sapin, V. and Bloom, F.E., Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism, Proc. Natl. Acad. Sci. USA, 78 (1981) 6535-6539.
41. Martin, J.L., Gasser, D. and Magistretti, P.J., Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide potentiate c-fos expression induced by glutamate in cultured cortical neurons, J. Neurochem., 65 (1995) 1-9.
42. Morrison, J.H., Rogers, J., Scherr, S., Benoit, R. and Bloom, F.E., Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients, Nature, 314 (1985) 90-92.
43. Mozurek, M.F., Beal, M.F., Malloy, J.R. and Martin, J.B., Vasoactive intestinal peptide immunoreactivity in Alzheimer cerebral cortex, Ann. Neurol., 20 (1986) 126.
44. Nakamura, S. and Vincent, S.R., Somatostatin and neuropeptide Y-immunoreactive neurons in the neocortex in senile dementia of Alzheimer's type, Brain Res., 370 (1986) 11-20.
45. Nawa, H., Nakanish, S. and Patterson, P.H., Recombinant cholinergic differentiation factor (leukemia inhibitory factor) regulates sympathetic neurons phenotype by alteration in the size and amounts of neuropeptides mRNAs, J. Neurochem., 56 (1991) 2147-2150.
46. Nilsson, J., Euler, A.M. and Dalsgaard, C.J., Stimulation of connective tissue cell growth by substance P and substance K, Nature, 315 (1985) 61-63.
47. Panlilio, L.V., Hill, J.M., Brenneman, D.E., Fridkin, M., Gozes, I. and Glowa, J.R., GP120 and a VIP antagonist impair Morris water maze performance in rats, Soc. Neurosci. Abstr., 16 (1990) 1330.
48. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, Australia, 1986.
49. Perry, E.K., Blessed, G. and Tomlinson, B.E., Neurochemical activities in human temporal lobe related to aging and Alzheimer-type change, Neurobiol. Aging, 2 (1981a) 251-256.
50. Perry, R.H., Dockray, G.J., Dimaline, R., Perry, E.K., Blessed, G. and Tomlinson, B.E., Neuropeptides in Alzheimer's disease, depression and schizophrenia: A post mortem analysis of vasoactive intestinal peptide and cholecytokinin in cerebral cortex, J. Neurol. Sci., 51 (1981b) 465-472.
51. Raadsheer, F.C., Oorschot, D.E., Verwer, R.W.H., Tilders, F.J.H. and Swaab, D.F., Age-related increase in the total number of corticotropin-releasing hormone neurons in the human paraventricular nucleus in controls and Alzheimer's disease: comparison of the disector with an unfolding method, J. Comp. Neurol., 339 (1994) 447-457.
52. Redmond, D.E. and Huang, Y.H., New evidence for a locus coeruleus-norepinephrine connection with anxiety, Life Sci., 25 (1979) 2149-2162.
53. Reid, A.M., Shulkes, A. and Tichen, D.A., Effects of the vagus nerves on gastric motility and release of vasoactive intestinal polypeptide in the anaesthetized lamb, J. Physiol. 396 (1988) 11-24.
54. Said, S.I. (Ed.), Vasoactive Intestinal Polypeptide: Advances in Peptide Hormone Research, Raven, New York, 1982.
55. Said, S.I. and Mutt, V., Vasoactive intestinal peptide and related peptides, Ann. NY Acad. Sci., (1988) 527.
56. Sanders, D.J., Zahedi-Asl, S. and Marr, A.P., Glucagon and CCK in the human brain: controls and patients with senile dementia of Alzheimer type. In R.M. Buijs, P. Pevet, D.F. Swaab (Eds.), Chemical Transmission of the Brain: the Role of Amines, Amino Acids and Peptides, Progress in Brain Research, Vol. 55, Elsevier, 1982, pp. 465-471.
57. Siever, L.J. and Davies, K.L., Overview: Towards a dysregulation hypothesis of depression, Am. J. Psychiatry, 142 (1985) 1017-1031.
58. Smeyne, R.J., Vendrell, M., Hayward, M., Baker, S.J., Miao, G.G., Schilling, K., Robertson, L.M., Curran, T. and Morgan, J.I., Continuous c-fos expression precedes programmed cell death in vivo, Nature, 363 (1993) 166-169.
59. Terry, R.D., Peck, A., DeTeresa, R., Schechter, R. and Horoupian, D.S., Some morphometric aspects of the brain in senile dementia of the Alzheimer type, Ann. Neurol., 10 (1981) 184-192.
60. Unger, J.W. and Schmidt, Y., Neuropeptide Y and somatostatin in the neocortex of young and aging rats: response to nucleus basalis lesions, J. Chem. Neuroanat., 7 (1994) 25-34.
61. Wang, Z.P., Man, S.Y. and Tang, F., Age-related changes in the contents of neuropeptides in the rat brain and pituitary, Neurobiol. Aging, 14 (1993) 529-534.
62. Zoli, M., Ferraguti, F., Toffano, G., Fuxe, K. and Agnati, L.F., Neurochemical alterations but not nerve cell loss in aged rat neostriatum, J. Chem. Neuroanat., 6 (1993) 131-145.